US 11155523
Biphenyl compound as CCR2/CCR5 receptor antagonist
granted A61PA61P29/00
Quick answer
US patent 11155523 (Biphenyl compound as CCR2/CCR5 receptor antagonist) held by Medshine Discovery Inc. expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61P, A61P29/00